Baker Biotech Capital (GP), LLC Insider Trading $GHDX GENOMIC HEALTH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Baker Biotech Capital (GP), LLC in GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 1,484,977 shares
Current Value: $40,822,018
Latest Transaction: Mar 09 2012
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in GENOMIC HEALTH INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, GHDX, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 30.36 | 2,162 | 65,647 | 1,484,977 | 1.5 M to 1.5 M (+0.15 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.88 | 2,346 | 70,097 | 1,482,815 | 1.5 M to 1.5 M (+0.16 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 30.07 | 8,372 | 251,736 | 1,480,469 | 1.5 M to 1.5 M (+0.57 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.96 | 10,225 | 306,301 | 1,472,097 | 1.5 M to 1.5 M (+0.70 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.52 | 10,972 | 323,899 | 1,461,872 | 1.5 M to 1.5 M (+0.76 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.47 | 1,763 | 51,956 | 1,450,900 | 1.4 M to 1.5 M (+0.12 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.06 | 19,552 | 568,144 | 1,449,137 | 1.4 M to 1.4 M (+1.37 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.11 | 5,934 | 172,730 | 1,429,585 | 1.4 M to 1.4 M (+0.42 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.03 | 4,270 | 123,961 | 1,423,651 | 1.4 M to 1.4 M (+0.30 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.12 | 7,477 | 210,282 | 1,419,381 | 1.4 M to 1.4 M (+0.53 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.98 | 638 | 17,852 | 1,411,904 | 1.4 M to 1.4 M (+0.05 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.98 | 5,217 | 145,955 | 1,411,266 | 1.4 M to 1.4 M (+0.37 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.85 | 10,838 | 323,566 | 1,406,049 | 1.4 M to 1.4 M (+0.78 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.61 | 11,021 | 326,338 | 1,395,211 | 1.4 M to 1.4 M (+0.80 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.96 | 41 | 1,187 | 1,384,190 | 1.4 M to 1.4 M (0.00 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.88 | 3,944 | 113,892 | 1,384,149 | 1.4 M to 1.4 M (+0.29 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.44 | 7,341 | 208,756 | 1,380,205 | 1.4 M to 1.4 M (+0.53 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.52 | 4,378 | 116,089 | 1,372,864 | 1.4 M to 1.4 M (+0.32 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.62 | 2,865 | 76,272 | 1,368,486 | 1.4 M to 1.4 M (+0.21 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.60 | 17,339 | 461,275 | 1,365,621 | 1.3 M to 1.4 M (+1.29 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.24 | 615 | 16,135 | 1,348,282 | 1.3 M to 1.3 M (+0.05 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.33 | 7,858 | 206,873 | 1,347,667 | 1.3 M to 1.3 M (+0.59 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.27 | 387 | 10,166 | 1,339,809 | 1.3 M to 1.3 M (+0.03 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.26 | 9,891 | 259,692 | 1,339,422 | 1.3 M to 1.3 M (+0.74 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.18 | 22,251 | 582,436 | 1,329,531 | 1.3 M to 1.3 M (+1.70 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.17 | 999 | 26,139 | 1,307,280 | 1.3 M to 1.3 M (+0.08 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.39 | 1,385 | 39,320 | 1,306,281 | 1.3 M to 1.3 M (+0.11 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.50 | 1,992 | 56,772 | 1,304,896 | 1.3 M to 1.3 M (+0.15 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.06 | 12,123 | 340,128 | 1,302,904 | 1.3 M to 1.3 M (+0.94 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.03 | 3,940 | 110,458 | 1,290,781 | 1.3 M to 1.3 M (+0.31 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.33 | 26,537 | 725,256 | 1,286,841 | 1.3 M to 1.3 M (+2.11 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 25.88 | 1,618 | 41,874 | 1,260,304 | 1.3 M to 1.3 M (+0.13 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 25.71 | 655 | 16,841 | 1,258,686 | 1.3 M to 1.3 M (+0.05 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.03 | 1,628 | 42,377 | 1,258,031 | 1.3 M to 1.3 M (+0.13 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 25.91 | 1,630 | 42,225 | 1,256,403 | 1.3 M to 1.3 M (+0.13 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.50 | 185 | 5,087 | 1,254,773 | 1.3 M to 1.3 M (+0.01 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.24 | 273 | 7,437 | 1,254,588 | 1.3 M to 1.3 M (+0.02 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.66 | 58 | 1,546 | 1,254,315 | 1.3 M to 1.3 M (0.00 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.80 | 484 | 12,973 | 1,254,257 | 1.3 M to 1.3 M (+0.04 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 24.49 | 115 | 2,816 | 1,253,773 | 1.3 M to 1.3 M (+0.01 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 24.42 | 5 | 122 | 1,253,658 | 1.3 M to 1.3 M (0.00 %) |
Page: 1